Philip J. Stella

A Randomized Phase IIIB Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared With Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer

J. Randolph Hecht, Edith P. Mitchell, Tarek Chidiac et al. · Journal of Clinical Oncology · 2008 · 851 citations · Full text

Multicenter Phase II and Translational Study of Cetuximab in Metastatic Colorectal Carcinoma Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidines

Heinz‐Josef Lenz, Eric Van Cutsem, Shirin Khambata‐Ford et al. · Journal of Clinical Oncology · 2006 · 536 citations · Full text

Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.

Debra L. Barton, Charles L. Loprinzi, Susan K. Quella et al. · Journal of Clinical Oncology · 1998 · 401 citations

Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With Gemcitabine Has Failed

Herbert I. Hurwitz, Nikhil Uppal, Stephanie A. Wagner et al. · Journal of Clinical Oncology · 2015 · 279 citations · Full text

A Phase II Study of PD-0325901, an Oral MEK Inhibitor, in Previously Treated Patients with Advanced Non–Small Cell Lung Cancer

Eric B. Haura, Alejandro D. Ricart, Timothy Larson et al. · Clinical Cancer Research · 2010 · 234 citations